Advanced Medical Solutions Grp PLC Notice of AGM and Management Change (4176Q)
06 June 2018 - 4:00PM
UK Regulatory
TIDMAMS
RNS Number : 4176Q
Advanced Medical Solutions Grp PLC
06 June 2018
6 June 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Notice of AGM and Management Change
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, will hold
its Annual General Meeting at 11.00 am today at 85 Gresham Street,
London, EC2V 7NQ. At the AGM, Chris Meredith, AMS's Chief Executive
Officer, will give a short presentation. No new material
information will be provided.
AMS also announces today that Mary Tavener intends to retire
from the role of Chief Financial Officer and Board Director on 31
December 2018, after 19 years with the Company. At the same time,
Eddie Johnson, who has been with AMS for more than six years, and
is currently Group Financial Controller, will assume the role of
Chief Financial Officer and join the Board.
Commenting on the announcement, Peter Allen, Non-Executive
Chairman of AMS, said: "I would like to thank Mary for her 19 years
of dedicated and outstanding service to AMS. In her time with the
Group, she has been integral to our listing on AIM, several
acquisitions and this has culminated in AMS growing for 13
consecutive years. At the same time, I would also like to
congratulate Eddie on his forthcoming appointment as Chief
Financial Officer and we look forward to welcoming him to the Board
in due course."
Edward ("Eddie") Johnson, 46, is not currently, nor has he been
in the last five years, a director or partner in any company or
partnership respectively. Other than as set out in this
announcement, there are no further disclosures required under
Schedule Two, paragraph (g) of the AIM Rules for Companies.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Nicholas AMS@consilium-comms.com
Brown
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Patrick Robb / Gary Clarence
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 600 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCKELFBVQFEBBK
(END) Dow Jones Newswires
June 06, 2018 02:00 ET (06:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024